Lnc2Cancer 2.0

High-throughput experiment

Lnc2Cancer 2.0 provides a high-throughput experiment page that enables users to browse lncRNA profiles in cancer by high-throughput experiment (microarray and RNA-seq). View our Help page for further help.

Pubmed ID	Cancer type	Sample	Design	Sample case	Sample control	Sample size	Up	Down	Availability
29335913	glioblastoma	tissues	case vs control	glioblastoma tissues	matched normal brain tissue		247	254
26697378	breast cancer	tissues	case vs control	triple-negative breast carcinomas tissues	adjacent normal breast tissues	3 vs 3			GSE64790
26952511	squamous cell lung carcinoma	cell lines	drug vs normal	lung carcinoma cell line with efficacy of 17 β-estradiol	lung carcinoma cell line
26786760	colorectal cancer	tissues	case vs control	plasma extracellular of Colorectal Cancer patients	plasma extracellular of healthy individuals	147 vs 50			GSE71008
27449296	HER2-positive breast cancer	tissues	drug vs normal	trastuzumab-resistant breast tumor tissues	trastuzumab-sensitive tumor tissues	11 vs 2
27432080	glioblastoma	tissues	case vs control	differentiated human glioblastoma stem cells	glioblastoma stem cells				GSE68343
27650541	B-cell precursor acute lymphoblastic leukemia	cell lines	case vs control	B-cell precursor acute lymphoblastic leukemia cell lines	control cell lines	13 vs 12			GSE79873
29176322	breast cancer	cell lines	cancer subtype	MDA-MB-231 cell line	MCF-7 cell line	1 vs 1
29279851	lung adenocarcinoma	cell lines	drug vs normal	A549, NCI-H1299 cells	cisplatin-resistant cell line A549/DDP
28203711	acute myeloid leukemia	tissues	case vs control	acute myeloid leukemia patients	non-leukemia controls	6 vs 2			GSE85030
28401021	intrahepatic cholangiocarcinoma	tissues	case vs control	intrahepatic cholangiocarcinoma tissues	normal tissues	4 vs 4	2148	568
28346506	childhood acute lymphoblastic leukemia	tissues	case vs control	blood of childhood acute lymphoblastic leukemia	control samples corresponding to CD10+ CD19+ pre-B cells	56 vs 3			GSE89071
28423571	diffuse large B-cell lymphoma	cell lines	case vs control	DLBCL cell lines	normal B cells	5 vs 3	416	637
28420424	hepatocellular carcinoma	tissues	case vs control	hepatocellular carcinoma tissues	normal tissues	3 vs 3			Additional files
28427191	colorectal cancer	tissues	case vs control	colorectal cancer tissues	normal tissues	3 vs 3	39	78
28468580	colorectal cancer	tissues	case vs control	colorectal cancer tissues	normal tissues	6 vs 6	556	1040
28468592	natural killer/T-cell lymphoma	tissues	case vs control	natural killer/T-cell lymphoma tissues	normal tissues	17 vs 3
29228655	hepatocellular carcinoma	tissues	case vs control	hepatocellular carcinoma tissues	normal tissues	3 vs 3
28580901	colorectal cancer	cell lines	drug vs normal	colorectal cancer cell lines treated with Nutlin-3a/5-FU	colorectal cancer cell lines	3 vs 3			GSE90086
28933981	lung cancer	tissues	case vs control	lung cancer tissues	normal tissues	3 vs 3
28428987	acute leukemia	tissues	case vs control	AML and ALL patient samples	normal bone marrow-derived mononuclear cells	12 vs 6			GSE96535
29109091	breast cancer	cell lines	drug vs normal	MDA-MB-231 cells of Boswellia Serrata	MDA-MB-231 cells	3 vs 3	265	65	GSE102891
29109091	breast cancer	cell lines	drug vs normal	MDA-MB-231 cells of 3-O-Acetyl-B-boswellic acid	MDA-MB-231 cells	3 vs 3	391	540	GSE102891
28960885	external auditory canal squamous cell carcinoma	tissues	case vs control	external auditory canal squamous cell carcinoma	normal external auditory canal epithelium	8 vs 8	3248	2373	GSE98912
29221148	gallbladder cancer	tissues	drug vs normal	LHQ experimental group	PBS solvent control group	3 vs 3	40	25
28849055	non-small cell lung cancer	cell lines	case vs control	SCC samples in NSCLC	tumor tissues of AC	18 vs 40	37	28	GSE10245
28881680	lung adenocarcinoma	tissues	case vs control	LUAD tumor tissues	paired adjacent non-tumor tissues	4 vs 4	63	112
29328463	papillary thyroid cancer	tissues	case vs control	PTC primary tumor tissues	non-cancerous thyroid samples	348 vs 58	440	340
29483846	lung adenocarcinoma	tissues	case vs control	cancerous	normal specimens	533 vs 59	29	90
29435279	acute lymphoblastic leukemia	blood	case vs control	children with acute lymphoblastic leukemia	healthy children	110 vs 120
29461598	head and neck squamous cell carcinoma	tissues	case vs control	HNSCC patients	healthy controls	366 vs 732
29436635	head and neck cancer tumor	tissues	case vs control	HPV-negative head and neck cancer tumors tissues	matched adjacent normal tissue	444 vs 44	3574	4058
29749396	multiple myeloma	cell lines	case vs control	CD138+ MM cells	normal donor plasma cells	308 vs 16	474	395
29069778	diffuse large B-cell lymphoma	tissues	case vs control	patients diagnosed with DLBCL	individuals without the history of DLBCL	114 vs 114
29069717	lung adenocarcinoma	tissues	case vs control	tumor samples	normal samples	571 vs 59
28487115	castration-resistant prostate cancer	cell lines	drug vs normal	castration resistant sublines	LNCaP cells	2 vs 1			GSE93929
28499919	glioblastoma	cell lines	drug vs normal	cell line U87MG	increasing concentrations of the drug		237	158
28391028	cervical cancer	cell lines	case vs control	SiHa/Np63a cells	SiHa/pCon cells		393	190
28714520	glioblastoma	cell lines	case vs control	cell line U87TR	cell line U87		1383	1309
28786067	hepatocellular carcinoma	cell lines		HepG2 cell line			88	97
28732076	lung adenocarcinoma	cell lines		MCF10A cells	MCF10A cells with EGF				ArrayExpress (E-MTAB-5370)
29137263	hepatocellular carcinoma	cell lines	drug vs normal	cell lines HepG2 and Huh7 with melatonin	cell lines HepG2 and Huh7	2 vs 2
28553938	hepatocellular carcinoma	cell lines		SMMC-7721 cells stably silencing MBNL3	SMMC-7721 cells	1 vs 1
29179477	breast cancer	tissues	case vs control	metastatic axillary nodes	luminal breast cancer tissues	5 vs 5
29228592	breast cancer	cell lines	drug vs normal	Dox-resistant cell lines	MCF-7	3 vs 1
29108251	renal cell carcinoma	cell lines		HOTAIR-overexpressing cell lines	control ACHN cells				GSE100107
28931862	papillomavirus-mediated cervical cancer	tissues	case vs control	cervical cancer tissues	mathched tissues	3 vs 3
29156779	nasopharyngeal carcinoma	cell lines	drug vs normal	cell line MKN45 with anti-cancer bioactive peptide (ACBP) and the chemotherapy drug oxaliplatin	cell line MKN45		914	472
28918047	colorectal cancer	tissues	case vs control	colorectal cancer tissues	corresponding normal tissues	6 vs 6	899	1646
28874676	Intraductal Papillary Mucinous Neoplasms of the Pancreas	tissues	case vs control	PDAC tumor tissue	adjacent normal tissue	5 vs 2
28713985	B-cell lymphoma	tissues	case vs control	GCB-DLBCL tissue	reactive lymph node tissue	10 vs 10
28854977	esophageal cancer	tissues	case vs control	esophageal tumor tissues	adjacent non-tumor tissues	5 vs 5			GSE89102
29657295	pancreatic ductal adenocarcinoma	tissues	case vs control	primary PDAC tissues	adjacent benign tissues	24 vs 15			GSE91035
28398609	breast cancer	tissues	case vs control	breast cancer tumor tissues	adjacent non-cancerous tissues	5 vs 5
28928863	pancreatic ductal adenocarcinoma	tissues	case vs control	pancreatic cancer tissues	adjacent normal tissues	5 vs 5
28819095	gastric cancer	tissues	case vs control	gastric cancer tissues	adjacent normal tissues	6 vs 6
28810927	liver cancer	tissues	case vs control	HCC cancerous tissues	corresponding adjacent noncancerous liver tissues	14 vs 14
29553098	cervical cancer	tissues	case vs control	cervical cancer tissues	normal tissues		510	1111
29290766	pancreatic cancer	cell lines	drug vs normal	PEX-treated DCs	normal DCs		1815	1412
29035381	hepatocellular carcinoma	tissues	case vs control	hepatocellular carcinoma tissues	normal tissues	115 vs 108	167	56
29387231	hepatocellular carcinoma	cell lines	case vs control	cirrhotic liver cells	control cells
29387224	ovarian cancer	tissues	case vs control	primary ovarian cancer tissues	omental metastasis tissues		179	56
29343207	pancreatic ductal adenocarcinoma	tissues	case vs control	pancreatic ductal adenocarcinoma	adjacent noncancerous tissues		1249	2130
29535820	breast cancer	cell lines	case vs control	breast cancer cell lines	normal cell lines				GSE72881
29194035	cervical cancer	tissues	case vs control	cervical cancer tissues	corresponding adjacent tissues		292	368
29258558	hepatocellular carcinoma	tissues	case vs control	hepatocellular carcinoma tissues	normal tissues
29282102	gastric cancer	tissues	case vs control	gastric cancer tissues	pair-matched normal tissues		1894	167
29276409	breast cancer	tissues	case vs control	breast cancer tissues	normal breast tissues		500	584
29215701	triple-negative breast cancer	tissues	case vs control	HER2 positive breast tumor tissues	normal breast tissues	114 vs 42	7	15	GSE50948
28947421	hepatocellular carcinoma	cell lines	case vs control	hepatocellular carcinoma cell lines	normal cell lines	2 vs 1
29050779	endometrial cancer	tissues	case vs control	endometrial cancer tissues	normal tissues
28767188	cervical cancer	cell lines	case vs control	cervical cancer cell lines	normal cell lines
28846832	breast cancer	cell lines	case vs control	breast carcinoma samples	paired normal samples	3 vs 3			GSE36953